Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Glowinski

Showing results (171-180 of 571) with videos related to

Pageof 58
Sort By:
Nature|October 15, 1981
Specific stimulation of in vitro maturation of mesencephalic dopaminergic neurones by striatal membranesA Prochiantz, M C Daguet, A Herbet, et al.
La Nouvelle Presse Medicale|June 27, 1981
[Gardner-Diamond syndrome in a male. Trial treatment with beta-blockers]J Glowinski, R Koubi, V May, et al.
Neurochemistry International|August 1, 1994
Presynaptic control of dopamine synthesis and release by excitatory amino acids in rat striatal synaptosomesA Chéramy, J M Desce, G Godeheu, et al.
Molecular Pharmacology|September 1, 1984
A new type of tachykinin binding site in the rat brain characterized by specific binding of a labeled eledoisin derivativeJ C Beaujouan, Y Torrens, A Viger, et al.
Brain Research|February 14, 1973
Some evidence for the existence of dopaminergic neurons in the rat cortexA M Thierry, L Stinus, G Blanc, et al.
Nature: New Biology|June 7, 1972
End product inhibition of serotonin synthesis in the rat striatumM Hamon, S Bourgoih, Y Morot-Gaudry, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 17, 1973
In vivo continuous estimation of 3 H-dopamine synthesis and release in the cat caudate nucleus. Effects of -methyl-p-tyrosine and of transection of the nigro neostriatal pathwayM J Besson, A Cheramy, C Gauchy, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1992
Nicotine and morphine differentially activate brain dopamine in prefrontocortical and subcortical terminal fields: effects of acute and repeated injectionsP Vezina, G Blanc, J Glowinski, et al.
Neuropeptides|June 1, 1997
Substance P(6-11) and natural tachykinins interact with septide-sensitive tachykinin receptors coupled to a phospholipase C in the rat urinary bladderY Torrens, M Saffroy, J Glowinski, et al.
Neuroscience Letters|February 28, 1994
Injections of 6-hydroxydopamine into the ventral tegmental area destroy mesolimbic dopamine neurons but spare the locomotor activating effects of nicotine in the ratP Vezina, D Hervé, J Glowinski, et al.
Pageof 58

Showing results (171-180 of 571) with videos related to

Sort By:
Pageof 58
Nature|October 15, 1981
Specific stimulation of in vitro maturation of mesencephalic dopaminergic neurones by striatal membranesA Prochiantz, M C Daguet, A Herbet, et al.
La Nouvelle Presse Medicale|June 27, 1981
[Gardner-Diamond syndrome in a male. Trial treatment with beta-blockers]J Glowinski, R Koubi, V May, et al.
Neurochemistry International|August 1, 1994
Presynaptic control of dopamine synthesis and release by excitatory amino acids in rat striatal synaptosomesA Chéramy, J M Desce, G Godeheu, et al.
Molecular Pharmacology|September 1, 1984
A new type of tachykinin binding site in the rat brain characterized by specific binding of a labeled eledoisin derivativeJ C Beaujouan, Y Torrens, A Viger, et al.
Brain Research|February 14, 1973
Some evidence for the existence of dopaminergic neurons in the rat cortexA M Thierry, L Stinus, G Blanc, et al.
Nature: New Biology|June 7, 1972
End product inhibition of serotonin synthesis in the rat striatumM Hamon, S Bourgoih, Y Morot-Gaudry, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 17, 1973
In vivo continuous estimation of 3 H-dopamine synthesis and release in the cat caudate nucleus. Effects of -methyl-p-tyrosine and of transection of the nigro neostriatal pathwayM J Besson, A Cheramy, C Gauchy, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1992
Nicotine and morphine differentially activate brain dopamine in prefrontocortical and subcortical terminal fields: effects of acute and repeated injectionsP Vezina, G Blanc, J Glowinski, et al.
Neuropeptides|June 1, 1997
Substance P(6-11) and natural tachykinins interact with septide-sensitive tachykinin receptors coupled to a phospholipase C in the rat urinary bladderY Torrens, M Saffroy, J Glowinski, et al.
Neuroscience Letters|February 28, 1994
Injections of 6-hydroxydopamine into the ventral tegmental area destroy mesolimbic dopamine neurons but spare the locomotor activating effects of nicotine in the ratP Vezina, D Hervé, J Glowinski, et al.
Pageof 58